These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 16339053
1. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. Victor JC, Surdina TY, Suleimenova SZ, Favorov MO, Bell BP, Monto AS. Am J Epidemiol; 2006 Feb 01; 163(3):204-10. PubMed ID: 16339053 [Abstract] [Full Text] [Related]
2. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP. N Engl J Med; 2007 Oct 25; 357(17):1685-94. PubMed ID: 17947390 [Abstract] [Full Text] [Related]
3. The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity. Victor JC, Surdina TY, Suleimeova SZ, Favorov MO, Bell BP, Monto AS. Epidemiol Infect; 2006 Jun 25; 134(3):492-7. PubMed ID: 16194291 [Abstract] [Full Text] [Related]
4. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Ceyhan M, Yildirim I, Kurt N, Uysal G, Dikici B, Ecevit C, Aydogan A, Koc A, Yasa O, Köseoğlu M, Onal K, Hacimustafaoglu M, Celebi S. J Viral Hepat; 2008 Oct 25; 15 Suppl 2():69-72. PubMed ID: 18837839 [Abstract] [Full Text] [Related]
5. Feasibility of vaccination in preventing secondary cases of hepatitis A virus infection. Sagliocca L, Bianco E, Amoroso P, Quarto M, Richichi I, Tosti ME, Carannante N, Chironna M, Chiriacò P, Di Bari G, Lopalco P, Resta F, Santantonio T, Tantimonaco G, Mele A. Vaccine; 2005 Jan 04; 23(7):910-4. PubMed ID: 15603892 [Abstract] [Full Text] [Related]
6. Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation. Costas L, Vilella A, Trilla A, Serrano B, Vera I, Roldán M, Sancho MP, Bayas JM, Gascón J, Costa J. J Travel Med; 2009 Jan 04; 16(5):344-8. PubMed ID: 19796106 [Abstract] [Full Text] [Related]
7. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Lee D, Cho YA, Park Y, Hwang JH, Kim JW, Kim NY, Lee DH, Lee W, Jeong SH. Intervirology; 2008 Jan 04; 51(2):70-4. PubMed ID: 18434743 [Abstract] [Full Text] [Related]
8. Risk factors of influenza transmission in households. Viboud C, Boëlle PY, Cauchemez S, Lavenu A, Valleron AJ, Flahault A, Carrat F. Br J Gen Pract; 2004 Sep 04; 54(506):684-9. PubMed ID: 15353055 [Abstract] [Full Text] [Related]
9. Active immunisation during an outbreak of hepatitis A in a German day-care centre. Hauri AM, Fischer E, Fitzenberger J, Uphoff H, Koenig C. Vaccine; 2006 Jul 17; 24(29-30):5684-9. PubMed ID: 16730103 [Abstract] [Full Text] [Related]
10. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up. Fisenka EG, Germanovich FA, Glinskaya IN, Lyabis OI, Rasuli AM. J Viral Hepat; 2008 Oct 17; 15 Suppl 2():57-61. PubMed ID: 18837836 [Abstract] [Full Text] [Related]
11. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program. Belmaker I, Dukhan L, Yosef Y, Leventhal A, Dagan R. Pediatr Infect Dis J; 2007 Jan 17; 26(1):36-40. PubMed ID: 17195703 [Abstract] [Full Text] [Related]
12. Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees. Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep; 2009 Sep 18; 58(36):1006-7. PubMed ID: 19763077 [Abstract] [Full Text] [Related]
13. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community. Barkai G, Belmaker I, Givon-Lavi N, Dagan R. Pediatr Infect Dis J; 2009 May 18; 28(5):391-3. PubMed ID: 19295466 [Abstract] [Full Text] [Related]
14. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine. Moisseeva AV, Marichev IL, Biloschitchkay NA, Pavlenko KI, Novik LV, Kovinko LV, Lyabis OI, Houillon G, Rasuli AM. J Viral Hepat; 2008 Oct 18; 15 Suppl 2():43-6. PubMed ID: 18837833 [Abstract] [Full Text] [Related]
15. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E, National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group. Clin Infect Dis; 2008 Mar 15; 46(6):868-75. PubMed ID: 18269332 [Abstract] [Full Text] [Related]
16. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. Mayorga Pérez O, Herzog C, Zellmeyer M, Loáisiga A, Frösner G, Egger M. J Infect Dis; 2003 Sep 01; 188(5):671-7. PubMed ID: 12934183 [Abstract] [Full Text] [Related]
17. The epidemiology and control of hepatitis A. Maguire H, Heptonstall J, Begg NT. Commun Dis Rep CDR Rev; 1992 Sep 11; 2(10):R114-7. PubMed ID: 1284926 [Abstract] [Full Text] [Related]
18. [Hepatitis A in Poland in 2003]. Magdzik W. Przegl Epidemiol; 2005 Sep 11; 59(2):289-95. PubMed ID: 16190532 [Abstract] [Full Text] [Related]
19. [Prevalence of anti-HAV antibodies in Warsaw population]. Janaszek-Seydlitz W, Bucholc B, Wiatrzyk A. Przegl Epidemiol; 2007 Sep 11; 61(4):675-82. PubMed ID: 18572499 [Abstract] [Full Text] [Related]
20. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A]. Zhao Y, Meng Z, Guo J, Wang X, Duo C, Liu H, Yao J, Chai S, Zhu H, Xu Z. Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May 11; 34(3):144-6. PubMed ID: 11860920 [Abstract] [Full Text] [Related] Page: [Next] [New Search]